Sanjiv has been with ChrysCapital since July 2004 and leads the healthcare and consumer sectors. He has 27 years of management experience in the pharmaceuticals industry prior to ChrysCapital, of which the last two decades were with Ranbaxy, one of India’s largest pharmaceutical companies. Sanjiv held several key leadership positions including country head for China, regional director for India and the Middle East and the vice president and head of corporate affairs for Ranbaxy. Sanjiv received an AMP from Harvard Business School, an MBA from Indian Institute of Management, Ahmedabad and is a pharmacy graduate.
Disclaimer: Please note that Clarus Trust, being registered as a Category III Alternative Investment Fund with the Securities and Exchange Board of India, is mandatorily required to raise funds only through private placement by issue of information memorandum or placement memorandum, by whatever name called, and is not permitted to solicit or collect funds except by way of private placement. Neither Clarus Trust nor its investment manager nor any of its or their respective officers and/or directors, solicit or have authorized the solicitation of investments from any person through any platform(s) (including group(s)/mobile application(s)) by posting messages or otherwise.